MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析

◆英語タイトル:MiMedx Group Inc (MDXG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH83319FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

MiMedx Group Inc Key Recent Developments

Mar 30,2021: MiMedx awarded amniotic tissue supplier agreement with Premier’s SURPASS Purchasing Program
Mar 08,2021: MiMedx announces fourth quarter and full year 2020 financial and operating results
Mar 03,2021: MiMedx to Participate at Upcoming Investor Conferences

This comprehensive SWOT profile of MiMedx Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MiMedx Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MiMedx Group Inc – Key Information
MiMedx Group Inc – Overview
MiMedx Group Inc – Key Employees
MiMedx Group Inc – Key Employee Biographies
MiMedx Group Inc – Key Operational Heads
MiMedx Group Inc – Major Products and Services
MiMedx Group Inc – History
MiMedx Group Inc – Company Statement
MiMedx Group Inc – Locations And Subsidiaries
MiMedx Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MiMedx Group Inc – Business Description
MiMedx Group Inc – Corporate Strategy
MiMedx Group Inc – SWOT Analysis
SWOT Analysis – Overview
MiMedx Group Inc – Strengths
MiMedx Group Inc – Weaknesses
MiMedx Group Inc – Opportunities
MiMedx Group Inc – Threats
MiMedx Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MiMedx Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MiMedx Group Inc, Key Information
MiMedx Group Inc, Key Ratios
MiMedx Group Inc, Share Data
MiMedx Group Inc, Major Products and Services
MiMedx Group Inc, History
MiMedx Group Inc, Key Employees
MiMedx Group Inc, Key Employee Biographies
MiMedx Group Inc, Key Operational Heads
MiMedx Group Inc, Other Locations
MiMedx Group Inc, Subsidiaries
MiMedx Group Inc, Key Competitors
MiMedx Group Inc, SWOT Analysis
MiMedx Group Inc, Ratios based on current share price
MiMedx Group Inc, Annual Ratios
MiMedx Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Meridian Bioscience Inc (VIVO):医療機器:M&Aディール及び事業提携情報
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, an …
  • Lundin Gold Inc:戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Genera Biosystems Ltd (GBI):製品パイプライン分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Dottikon ES Holding AG (DESN):製薬・医療:M&Aディール及び事業提携情報
    Summary Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company finds novel uses for hazardous reactions and continuous processing that facilitate the r …
  • NuStar Energy LP (NS):企業の財務・戦略的SWOT分析
    NuStar Energy LP (NS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • GMT Exploration Co LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary GMT Exploration Co LLC (GMT Exploration) is a oil and natural gas company. It is engaged in the generation, operation and development of oil and natural gas properties primarily located in Alaska, East Texas, Montana, New Mexico and Wyoming. The Company’s identifies, acquires and operates re …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bureau Veritas SA (BVI):石油・ガス:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • HiQ International AB (HIQ):企業の財務・戦略的SWOT分析
    Summary HiQ International AB (HiQ International) is a technology and communication company that offers management consultancy services. The company offers communications solutions, development of software, and business-critical IT systems. It provides services in the areas of telecom media, gaming a …
  • Aurizon Holdings Limited:企業の戦略・SWOT・財務情報
    Aurizon Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Aurizon Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Savola Group Co:戦略・SWOT・企業財務分析
    Savola Group Co - Strategy, SWOT and Corporate Finance Report Summary Savola Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NeuroGenetic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeuroGenetic Pharmaceuticals Inc (NeuroGenetic Pharmaceuticals) is a pharmaceutical company that develops drugs for Alzheimer’s diseases. The company develops products with its gamma-secretase modulators technology. It applies multiple lead compounds for the treatment of neurodegenerative co …
  • E.ON UK Plc:企業の発電所・SWOT分析2018
    E.ON UK Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • CLP Holdings Ltd (2)-エネルギー分野:企業M&A・提携分析
    Summary CLP Holdings Limited (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s gener …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆